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Development of allergic contact dermatitis to
haptens depends upon a balance between CD8+
T lymphocytes with pathogenic activity and CD4+
T cells, which comprise both effector and regulatory
cells. Thus, differential recruitment of CD8+ and
CD4+ lymphocytes to sites of hapten challenge may
have considerable impact on disease expression.
Here the migration of cutaneous lymphocyte-associ-
ated antigen+, nickel-speci®c CD8+ and CD4+ T cell
lines were compared with a panel of chemokines
produced in the skin during allergic contact derma-
titis. CCL17/TARC and CCL22/MDC induced a
3-fold higher migration of CD4+ compared with
CD8+ lymphocytes. In contrast, CXCL10/IP-10 was
2-fold more potent in attracting CD8+ cells. These
®ndings were consistent with the higher expression
of CCR4 and CXCR3 on CD4+ and CD8+ T cell
lines, respectively. Moreover, CCR4 expression was
high on nickel-speci®c T helper 2, intermediate on
T helper 1 and T cytotoxic 2, and almost undetect-
able on T cytotoxic 1 clones. On the contrary,
CXCR3 was expressed by T cytotoxic 1 and 2 and
T helper 1, but not T helper 2 clones. Reverse tran-
scription±polymerase chain reaction analysis of the
skin before and after hapten challenge revealed the
constitutive presence of TARC, and the early
appearance of CCL2/MCP-1, followed by IP-10,
CCL4/MIP-1b, and MDC mRNA. Supernatants
from activated keratinocytes induced a strong migra-
tion of CD8+ lymphocytes, which was blocked by
neutralization of IP-10. Conversely, supernatants
from immature and mature dendritic cells attracted
mostly CD4+ lymphocytes in a TARC- and MDC-
dependent manner. Our data indicate that distinct
chemokines and cell types control the accumulation
of CD8+ and CD4+ T cells within in¯amed skin. Key
words: allergic contact dermatitis/chemokines/leukocyte
traf®cking/skin. J Invest Dermatol 118:1052±1058, 2002
A
llergic contact dermatitis (ACD) is a common disease
due to an unbalanced immune response to skin-
applied haptens (Cavani et al, 2001). CD8+ T
lymphocytes are principally responsible for the
expression of both human ACD and murine contact
hypersensitivity, given their attitude to release type 1 cytokines and
mediate tissue damage through ef®cient cytotoxic mechanisms
(Bour et al, 1995; Xu et al, 1996; Bouloc et al, 1998; Cavani et al,
1998; Kehren et al, 1999; Traidl et al, 2000). Among CD4+
lymphocytes, T helper (Th) 1 cells augment disease expression by
secreting pro-in¯ammatory cytokines and damaging activated
keratinocytes (Traidl et al, 2000; Trautmann et al, 2000; Wang et
al, 2000). In contrast, hapten-speci®c CD4+ interleukin (IL)-10
producing T cells with regulatory functions prevent and/or limit
the magnitude of ACD and contact hypersensitivity by blocking
dendritic cell (DC) function (DiIulio et al, 1996; Cavani et al, 2000;
Schwarz et al, 2000). Finally, evidence has been provided that Th2
lymphocytes suppress contact hypersensitivity in mice, but their
role in human disease is still controversial (Albanesi et al, 2000;
Biedermann et al, 2001).
Chemokines are a vast superfamily of small chemotactic proteins
that regulate the traf®c and tissue homing of leukocytes (Rossi and
Zlotnik, 2000; Zlotnik and Yoshie, 2000; Mackay, 2001). During
ACD, lymphocyte recruitment is promoted by the sequential and
coordinated release of chemokines from skin resident and
immigrated cells (Goebeler et al, 2001). Polarized Th1 and Th2
cells display distinct chemokine receptor assets and are thus
selectively recruited to sites of in¯ammation. CXCL10/IP-10,
CXCL9/Mig, CXCL11/I-TAC, and CCL4/MIP-1b preferen-
tially attract Th1 lymphocytes thanks to the high CXCR3 and
CCR5 expression. CCL11/eotaxin, CCL17/TARC, CCL22/
MDC, and CCL1/I-309 are active on Th2 cells, which express
CCR3, CCR4, and CCR8 (Bonecchi et al, 1998; D'Ambrosio et
al, 1998; Loetscher et al, 1998; Sallusto et al, 1999). IL-10
producing regulatory T lymphocytes express both Th1- and Th2-
associated receptors and are particularly responsive to I-309
(Sebastiani et al, 2001). Chemokine receptors are also involved in
the selective tissue targeting of T lymphocytes, and most skin-
homing CD4+ T cells express CCR4, independently from their
cytokine production pro®le. CCR4 triggering by TARC exposed
on the surface of activated endothelium induces the ®rm adhesion
of circulating lymphocytes, by promoting T cell integrin activation
(Campbell et al, 1999). In contrast to the large body of information
regarding the migratory behavior of CD4+ lymphocytes, the
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chemokine receptor asset and the migratory responsiveness to
chemotactic stimuli of T cytotoxic (Tc) 1 and Tc2 CD8+
lymphocytes has been poorly investigated. Murine type 1 and
type 2 CD4+ and CD8+ lymphocytes have been shown to express
similar patterns of CCR5, CCR4, and CCR3 (Cerwenka et al,
1999), whereas human CD8+ T cells appear to express higher levels
of CXCR3 and respond more promptly to IP-10 and Mig,
compared with CD4+ cells (Rabin et al, 1999).
Given the different role of CD8+ and CD4+ T lymphocytes in
the immune responses to haptens, we compared the migratory
behavior of skin-homing T cells with a panel of chemokines
expressed during ACD. Our results show that CD8+ and CD4+ T
cell subsets exhibit different levels of CXCR3 and CCR4
chemokine receptors. As a consequence, IP-10 secreted by
activated keratinocytes preferentially controls the recruitment of
CD8+ T lymphocytes, whereas TARC and MDC released by DC
mostly promote CD4+ T lymphocytes migration.
MATERIALS AND METHODS
Culture medium, antibodies, and chemokines T lymphocytes and
DC were cultured in RPMI 1640 supplemented with 2 mM glutamine,
1 mM sodium pyruvate, 1% nonessential amino acids, 0.05 mM 2-
mercaptoethanol, 100 U penicillin per ml, and 100 mg streptomycin per
ml (Invitrogen Italia, San Giuliano Milanese, Italy) (complete RPMI)
plus 10% heat-inactivated fetal bovine serum (Hyclone Logan, UT) or
5% autologous plasma. The monoclonal antibody (MoAb) anti-CCR4
(328B, IgG) was kindly provided by ICOS Corp. (Bothell, WA). Mouse
MoAb anti-CCR5 (45531.111, IgG2B), and anti-CXCR3 (49801.111,
IgG1) were supplied by R&D Systems (Abingdon, U.K.). Anti-CD3
MoAb (UCHT-1, IgG1) was purchased from Immunotech (Marseille,
France). Anti-CD28 (Leu-28, IgG1), ¯uorescein isothiocyanate (FITC)-
conjugated anti-cutaneous lymphocyte associated antigen (CLA; HECA-
452, rat IgM), anti-CD4 (RPA-T4, IgG1), anti-CD8 (RPA-T8, IgG1),
and anti-interferon (anti-IFN)-g (4S.B3, IgG1), phycoerythrin-
conjugated anti-IL-4 (MP4±25D2, rat IgG1), and control mouse and rat
immunoglobulin were from BD Pharmingen (San Diego, CA).
Secondary FITC- or phycoerythrin-conjugated goat anti-mouse IgG
were from Dako (Glostrup, Denmark). Recombinant human MIP-1b,
MCP-1, eotaxin, TARC, MDC, I-309, IL-8, and IP-10, as well as
neutralizing anti-IP-10 (33036.211, IgG1) and anti-MDC (57226.11,
IgG2B) MoAb were purchased from R&D Systems. The rabbit
polyclonal anti-TARC antibody was from PeproTech (London, U.K.).
Nickel-speci®c T cell lines and clones Short-term nickel-speci®c
CD4+ and CD8+ T cell lines were obtained from peripheral blood of
three patients with ACD to nickel, as previously described (Cavani et al,
1998). Brie¯y, peripheral blood mononuclear cells (PBMC) were
separated by centrifugation over Ficoll-Hypaque (Lymphoprep,
Nycomed-Pharma, Oslo, Norway) and left to adhere (6 3 106 cells per
ml) in Petri dishes for 2 h at 37°C in complete RPMI with 5%
autologous plasma. The nonadherent fraction was depleted of CD19+,
CD56+, HLA-DR+, and CD8+ or CD4+ cells by incubation with
Figure 1. Nickel-speci®c CD4+ and CD8+ T cell lines express
similar levels of CLA, and are predominantly composed of type 1
cells. T cell lines were generated from puri®ed peripheral blood CD4+
and CD8+ T cell fractions, and cultured with irradiated autologous
PBMC and 10 mg NiSO4 per ml. (A)Antigen speci®city of T cell lines
was assayed by measuring thymidine uptake after 5 day activation with
irradiated PBMC and NiSO4. Results are expressed as mean cpm 6 SD
of triplicate cultures. (B)Expression of CLA (bold histograms) by a
representative CD4+ and CD8+ T cell lines. Thin histograms are staining
with control rat IgM. (C)Secretion of IFN-g, IL-4, and IL-10 was
evaluated 48 h after activation with anti-CD3 and anti-CD28 MoAb.
Results are expressed as mean 6 SD ng per ml of triplicate wells.
Figure 2. CD4+ and CD8+ T cell lines migrate preferentially to
MDC/TARC and IP-10, respectively. Migratory responses to various
concentrations of CC and CXC chemokines were examined in resting
nickel-speci®c CD4+ (h) and CD8+ (j) T cell line. Data are expressed
as net migration, which represent the difference between the number of
cells migrated with the agonistic chemokine and the number of cells
migrated with medium alone (mean 6 SD).
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immunomagnetic beads coated with speci®c MoAb (Dynabeads M450,
Dynal, Oslo, Norway) to obtain > 95% pure CD4+ and CD8+ T cells,
respectively. T cells were then cultured with irradiated autologous
PBMC and 10 mg NiSO4 per ml (Sigma-Aldrich, Milan, Italy) to enrich
for nickel-speci®c T cells. T cell lines were cloned by limiting dilution
(0.5 cell per well in 96-well U-bottomed microplates) in complete
RPMI plus 10% fetal bovine serum in the presence of irradiated
allogeneic feeder cells, 1% phytohemagglutinin and 30 U IL-2 per ml.
Antigen speci®city of T cell lines and clones was assessed by measuring
[3H]thymidine incorporation after 2±5 d activation with irradiated
PBMC and NiSO4 in complete RPMI supplemented with 5%
autologous plasma. Polarized CD4+ and CD8+ T cell lines were
obtained from puri®ed CD4+ and CD8+ T cell fractions after two
stimulations with 1% phytohemagglutinin in the presence of 2 ng IL-12
per ml plus 10 mg anti-IL-4 per ml, or 200 U IL-4 per ml plus 10 mg
anti-IL-12 per ml (R&D Systems) to induce a type 1 and type 2
phenotype, respectively.
Keratinocyte cultures Epidermal sheets were obtained from the roof
of suction blisters raised on the forearms of healthy donors and
disaggregated to single-cell suspension using 0.5% trypsin (Biochrom,
Berlin, Germany). Keratinocyte primary cultures were established by
seeding epidermal cells on a feeder layer of irradiated 3T3/J2 ®broblasts
and cultured in modi®ed Green's medium, as described (Traidl et al,
2000). Second or third passage keratinocytes were cultured in
keratinocyte growth medium (Clonetics, San Diego, CA) without
hydrocortisone and bovine pituitary extract, and supplemented with
0.1% bovine serum albumin for at least 3 d before activation with 300 U
IFN-g per ml and 50 mg tumor necrosis factor (TNF)-a per ml (R&D
Systems). Supernatants were collected 48 h after activation.
DC preparation DC were prepared from the adherent fraction of
PBMC of healthy individuals, as reported previously (Cavani et al, 2000).
DC were cultured at 1 3 106 cells per ml in complete RPMI 1640
supplemented with 10% fetal bovine serum, 200 ng human granulocyte-
macrophage colony-stimulating factor per ml (Mielogen, Schering-
Plough, Milan, Italy) and 200 U IL-4 per ml at 37°C with 5% CO2.
Medium was changed after 3 d and cells were used at day 7 of culture.
This procedure gave > 97% pure CD1a+ and CD14± DC preparations.
DC maturation was induced by adding 10 mg lipopolysaccharide per ml
(from Escherichia coli 055:B5; Sigma-Aldrich) for the last 24 h of culture,
and con®rmed by CD83 upregulation (data not shown).
Flow cytometry analysis Resting CD4+ and CD8+ T cells were
washed in PBS (2% fetal bovine serum and 0.01% NaN3), and then
stained with FITC-conjugated MoAb or with pure MoAb followed by
FITC-conjugated anti-mouse secondary antibody. Staining with matched
isotype control immunoglobulins were included. For detection of
intracellular cytokines, T cell lines were activated with phorbol-
myristate-acetate (10 ng per ml) plus ionomycin (1 mg per ml) for 6 h.
Monensin (10 mM; Sigma-Aldrich) and brefeldin A (10 mg per ml;
Sigma-Aldrich) were added into the cultures prior to the staining to
prevent cytokine secretion. T lymphocytes were then ®xed with 2%
paraformaldehyde, permeabilized with 0.5% saponin, stained with FITC-
conjugated anti-IFN-g and phycoerythrin-conjugated anti-IL-4, and
analyzed with a FACScan equipped with Cell Quest software (Becton
Dickinson). Data analysis was performed using WinMDI software
(http://facs.scripps.edu).
Cytokine and chemokine enzyme-linked immunosorbent
assay Supernatants from T cells stimulated in 24-well plates with
immobilized anti-CD3 and soluble anti-CD28 (both at 1 mg per ml)
MoAb were collected after 48 h, ®ltered, and tested for IL-10, IL-4, and
IFN-g content by enzyme-linked immunosorbent assay kits from R&D
Systems. Cell-free supernatants from keratinocyte and DC cultures were
tested for IP-10 using the puri®ed 4D5/A7/C5 and the biotinylated
6D4/D6/G2 anti-human IP-10 MoAb (BD Pharmingen). MDC and
TARC were detected with enzyme-linked immunosorbent assay kits
from R&D Systems. Cell cultures were carried out in triplicate for each
condition.
Migration assay Lymphocyte migration was evaluated through a 5 mm
pore polycarbonate ®lters in 24-well transwell chambers (Corning
Costar, Cambridge, MA), as described (Bonecchi et al, 1998). Brie¯y,
resting CD4+ and CD8+ were added to the top chamber suspended in
complete RPMI plus 0.5% bovine serum albumin at 106 cells per ml.
Recombinant chemokines or supernatants from keratinocyte or DC
cultures were added to the bottom chamber of the transwell (0.6 ml). In
blocking experiments, supernatants were preincubated with anti-IP-10
(20 mg per ml) or with a mixture of anti-MDC and anti-TARC (10 mg
per ml each), or control mouse IgG before addition to the bottom
chamber. After 1 h incubation at 37°C with 5% CO2, cells transmigrated
into the lower chamber were recovered and counted with a FACScan
for 60 s at a ¯ow rate of 60 ml per min, as described (Sebastiani et al,
2001). Results are shown as net migration, which represents the
difference between the cells migrated in response to the agonistic
chemokine or the supernatant and the medium alone.
Figure 3. Chemokine receptor expression in resting nickel-
speci®c T cell lines and clones. CD4+ and CD8+ T cell lines (A) and
T cell clones (B) were stained with MoAb speci®c for chemokine
receptors (bold histograms) or with isotype control immunoglobulin
(thin histograms), followed by FITC-conjugated secondary antibody, and
then examined with a FACScan. Numbers indicate the net mean
¯uorescence intensity. Results are representative of three T cell lines and
20T cell clones prepared from three different donors.
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Reverse transcription±polymerase chain reaction (PCR)
analysis Total cellular RNA was extracted from 4 mm punch skin
biopsies obtained at different time points (0±60 h) after the application of
5% NiSO4 on the back of adult patients with ACD to nickel (n = 2),
using the acid guanidinium thiocyanate±phenol±chloroform method.
Total RNA (0.5±1 mg) was reverse transcribed using oligo-dT primers
and then subjected to ampli®cation with a GeneAmp RNA PCR kit
(Perkin Elmer, Roche Molecular Systems, Branchburg, NJ). The
following synthetic oligonucleotides were used:
MCP-1: ATA GCA GCC ACC TTC ATT C (5¢) and TTC CCC
AAG TCT CTG TAT CT (3¢)
IP-10: TCT AAG TGG CAT TCA AGG AGT ACC (5¢) and CAG
TAA ATT CTT GAT GGC CTT CGA (3¢)
TARC: AGA GGG ACC TGC ACA CAG AGA CTC (5¢) and
AGG CTT CAA GAC CTC TCA AGG CTT T (3¢)
MIP-1b: GAA GCT CTG CGT GAC TGT CCT GTC (5¢) and
CAG GTC ATA CAC GTC CTC CTG GAC (3¢)
MDC: AGA AAC CTT GGT CCA ACT AGT GGA G (5¢) and
GAG CCT TCC TGG AGG AGC CAA (3¢)
The b-actin house-keeping gene was ampli®ed with TGA CGG GGT
CAC CCA CAC TGT GCC CAT CTA (5¢) and CTA GAA GCA
TTT GCG GTG GAC GAT GGA GGG (3¢) primers. For quantitative
analysis, RNA concentrations, primers, and PCR cycles were titrated to
obtain standard curves to verify linearity, and to permit analysis of signal
strength.
Statistical analysis The Mann±Whitney test was used to compare
differences in cell migration. p < 0.05 was considered signi®cant.
RESULTS AND DISCUSSION
Nickel-speci®c CD4+ and CD8+ T cell lines migrate
differently to chemokines To investigate the migratory
behavior of skin-seeking hapten-speci®c T cells, CD4+ and
CD8+ lines were puri®ed from the blood of patients with ACD
to nickel and stimulated in vitro in the presence of NiSO4 to expand
speci®c T cell populations (Fig 1A). The majority of T
lymphocytes in both CD4+ (70 6 15%, n = 3) and CD8+
(62 6 12%, n = 3) T cell lines was CLA+ (Fig 1B), indicating
their ability to recirculate in the skin. Upon stimulation with
nickel, T cell lines uniformly expressed a type 1 cytokine pro®le,
with high IFN-g and low IL-4 release, whereas IL-10 secretion was
more pronounced in CD4+ compared with CD8+ cells (Fig 1C).
Migration experiments showed that CD4+ lymphocytes were more
responsive to the CCR4 ligands TARC and MDC compared with
CD8+ T cells. On the contrary, CD8+ lymphocytes migrate to a
higher extent to IP-10 (CXCR3 ligand). I-309 and MCP-1
induced slightly higher responses in CD4+ and CD8+ T
lymphocytes, respectively, whereas both cell types were equally
attracted by MCP-1, and scarcely to eotaxin and IL-8 (Fig 2).
Taken together, these data strongly suggest that TARC and MDC
are crucial to direct CD4+ T lymphocytes migration, but play only
a minor part in attracting CD8+ T cells, con®rming the
fundamental role of TARC in the skin homing of CLA+ CD4+
lymphocytes (Campbell et al, 1999). On the contrary, IP-10 results
2-fold more potent in attracting CD8+ T lymphocytes compared
with CD4+ T cells. The importance of CXCR3 agonists in
governing the recruitment of both memory and naive CD8+ cells,
as well as that of CD8+, T cell receptor ab+ thymocytes, has been
repeatedly con®rmed (Rabin et al, 1999; Agostini et al, 2000;
Romagnani et al, 2001). In addition, the great majority of CD8+ T
cells in®ltrating acute ACD reactions have been shown to express
the CXCR3 receptor (Albanesi et al, 2000). Other reports,
however, did not reveal signi®cant differences between CD4+
and CD8+ T cell migration to IP-10 during viral-induced
neurologic disease and acute cardiac allograft rejection in mouse
models (Liu et al, 2000; Hancock et al, 2001). Finally, we could not
con®rm the preferential migration of CD4+ vs CD8+ T
lymphocytes to MIP-1b and MCP-1 (Taub et al, 1993; Rabin et
al, 1999).
Chemokine receptor expression on nickel-speci®c T cell
subsets To investigate whether the different migratory behavior
Figure 4. Chemokine receptor expression on
in vitro polarized CD4+ and CD8+ T cells.
Type 1 and type 2 CD4+ and CD8+ T cell lines
were obtained from puri®ed peripheral blood
CD4+ and CD8+ T cells after two stimulations
with phytohemagglutinin in the presence of 2 ng
IL-12 per ml plus 10 mg anti-IL-4 per ml, or
200 U IL-4 per ml plus 10 mg anti-IL-12 per ml.
T cells were assayed for intracellular IFN-g and
IL-4 after activation with PMA and ionomycin.
Resting cells were stained with speci®c MoAb
(bold histograms) or with isotype control
immunoglobulin (thin histograms), followed by
FITC-conjugated secondary antibody. Numbers
indicate the percentage of cytokine producing
cells or the net mean ¯uorescence intensity of
chemokine receptors. Results are representative of
three T cell lines for each condition from three
different subjects.
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of nickel-speci®c CD4+ and CD8+ lymphocytes re¯ected a distinct
chemokine receptor asset, CXCR3, CCR4, and CCR5 expression
was examined by ¯uorescence-activated cell sorter analysis on
resting T cell lines. In spite of their similar cytokine pro®le, CD4+
and CD8+ T lymphocytes differed in their CXCR3 expression,
which was higher on CD8+ T cells compared with CD4+ T cells.
Conversely, CCR4 staining was stronger on CD4+ than on CD8+
T cell lines (Fig 3A). To examine the distribution of these
receptors in polarized CD8+ and CD4+ subsets, nickel-speci®c T
cell lines were cloned by limiting dilution and CLA+ type 1 and
type 2 clones were compared for CXCR3 and CCR4 expression.
CXCR3 was expressed at high levels on Tc1, Th1, and in lower
amounts on Tc2 clones, but it was only barely detectable on Th2
lymphocytes (Fig 3B). In contrast, CCR4 was highly expressed by
Th2, followed by Tc2 and Th1, but not by Tc1 clones. No
signi®cant differences were observed in CCR5 expression between
CD4+ and CD8+ T cell lines, whereas at the clonal level this
receptor was restricted to type 1 lymphocytes.
To see whether the different expression of CXCR3 and CCR4
on CD8+ and CD4+ T lymphocytes was a unique characteristic of
skin-homing T lymphocytes or a more general ®nding, in vitro
polarized T cell lines were examined. Puri®ed CD4+ and CD8+ T
lymphocytes stimulated with phytohemagglutinin in the presence
of IL-12 and anti-IL-4 MoAb, displayed a predominant type 1
polarization, whereas upon anti-IL-12 and IL-4 treatment T cells
displayed a type 2 pattern (Fig 4). CLA was expressed by less than
10% of both CD4+ and CD8+ T cells (data not shown).
Fluorescence-activated cell sorter analysis con®rmed a higher
CXCR3 level on Tc1 and Tc2 cells compared with Th1 and
Th2 lymphocytes, respectively. In contrast, CCR4 expression was
stronger on Th2 cells compared with Th1 lymphocytes, as
previously described ((Bonecchi et al, 1998). In addition, in vitro
polarized Th2 lymphocytes showed higher levels of CCR4 than
Tc2 and Tc1 cells. In comparison, the differences in the CCR4
expression on Th2 and Th1 CLA+ nickel-reactive lymphocytes
were less pronounced. CCR5 was expressed by type 1 cells,
Figure 5. Chemokine mRNA expression in ACD skin. Reverse
transcription±PCR analysis was performed on RNA extracted from skin
biopsies obtained from patients with ACD to nickel at time 0, and 12±
60 h after the application of 5% NiSO4 in petrolatum.
Table I. Chemokine released by keratinocytes and DCa
Keratinocytes DC
± IFN-g/TNF-a ± Lipopolysaccharide
IP-10 < 0.01 580 6 61 0.04 6 0.01 10 6 3
MDC < 0.01 0.43 6 0.03 72 6 8 480 6 66
TARC < 0.01 < 0.02 136 6 18 520 6 86
aSupernatant from keratinocyte cultures, either untreated or stimulated with
300 U IFN-g per ml and 50 mg TNF-a per ml for 48 h. Supernatants from
immature DC and DC cultured 24 h with 10 mg lipopolysaccharide per ml. Data
are expressed as mean ng per ml per 106 cells 6 SD of triplicate cultures for each
condition.
Figure 6. Keratinocyte-derived IP-10 and DC-derived MDC/
TARC attract predominantly CD8+ and CD4+ T cells,
respectively. Supernatants from untreated keratinocyte or DC cultures
(A) and keratinocytes activated with IFN-g plus TNF-a, or
lipopolysaccharide-treated DC (B) were used at 1 : 10 dilution in
migration assay for CD4+ and CD8+ nickel-speci®c T cells. Supernatants
were preincubated with anti-IP-10 MoAb or with anti-MDC MoAb and
anti-TARC antibody to neutralize the respective chemokines. p < 0.03
vs IgG-treated supernatant.
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without differences between CD4+ and CD8+ lymphocytes. Thus,
the preferential CD4+ and CD8+ migration to TARC/MDC and
IP-10, respectively, is paralleled by a distinct distribution of the
corresponding chemokine receptors on these T cell subsets.
Importantly, the more pronounced expression of CCR4 and
CXCR3 receptors on CD4+ and CD8+ cells is not limited to skin-
homing T cell subsets, but may represent a more general ®nding for
the recruitment of T cell subsets in diverse organ-speci®c
in¯ammatory conditions.
Chemokine expression in ACD skin Skin biopsies were taken
at different time points after NiSO4 application in patients with
ACD to nickel, and mRNA content was examined using reverse
transcription±PCR analysis (Fig 5). TARC mRNA was
constitutively expressed in normal skin, predominantly produced
by immature DC (Vissers et al, 2001), and slightly upregulated after
nickel challenge. In contrast, the mRNA for the other chemokines
was not detected in normal skin. MCP-1 mRNA appeared early
(12 h) after hapten application, whereas IP-10 signal was barely
detectable at 12 h, and strongly upregulated at 24±48 h. MDC and
MIP-1b mRNA showed a more delayed kinetics. The early
induction of MCP-1 in lesional ACD skin supports its role in the
initiation of the reaction (Rand et al, 1996; Goebeler et al, 2001).
This chemokine may direct an early in¯ux of both CD8+ and
CD4+ T lymphocytes secreting IFN-g, which in turn induces IP-
10 release from keratinocytes (Flier et al, 1999; Albanesi et al, 2000;
Goebeler et al, 2001). IP-10 can then further attract Th1 and CD8+
T cells in the skin leading to full ACD expression. Finally, TARC
and MDC may be involved in the early and late skin recruitment of
CD4+ lymphocytes, including Th2 and IL-10 producing T cells
(Sebastiani et al, 2001).
CD4+ and CD8+ migration in response to keratinocyte and
DC supernatants In situ hybridization studies have
demonstrated that during ACD to nickel IP-10 is mainly
expressed by keratinocytes, together with I-TAC (Flier et al,
1999; Goebeler et al, 2001). Moreover, keratinocytes stimulated
in vitro with IFN-g or Th1 supernatant are a major source of IP-10
(Flier et al, 1999; Albanesi et al, 2000). Keratinocytes also secrete
low amounts of MDC upon IFN-g/TNF-a stimulation, whereas
we were unable to demonstrate signi®cant release of TARC
(Albanesi et al, 2001). The most relevant source of MDC and
TARC in the skin are probably DC (Vulcano et al, 2001). In
particular, immature DC produce high basal levels of MDC and
TARC that are further increased upon maturation (Vissers et al,
2001). Given the different migration of CD4+ and CD8+ T cells to
these chemokines, it is reasonable to hypothesize that different cell
populations in the skin are responsible for the recruitment of
distinct T cell subsets. We thus evaluated the migratory capacity of
nickel-speci®c T cell lines in response to supernatants from
keratinocyte and DC cultures (Table I). Supernatant from resting
keratinocytes did not contain measurable levels of IP-10, MDC,
and TARC, and did not attract T lymphocytes. Immature DC
released MDC and TARC and negligible amounts of IP-10 and
attracted exclusively CD4+ T cells (Fig 6A). Supernatant from
IFN-g/TNF-a-activated keratinocytes contained high levels of IP-
10 and low amounts of MDC, and was very ef®cient in inducing
CD4+, and only some CD8+ T cell migration. Neutralization of
IP-10 in keratinocyte supernatant signi®cantly reduced CD4+
migration (47% inhibition), and almost completely blocked CD8+
migration (78% inhibition). TARC/MDC neutralization in
keratinocyte supernatant showed only marginal effects on both
CD4+ and CD8+ responses. Conversely, neutralization of TARC
and MDC in DC supernatant led to a 60±70% and 29% reduction
of CD4+ and CD8+ migration, respectively. Finally, blocking IP-
10 on DC supernatant had almost no effect on both CD4+ and
CD8+ T cell responses.
IP-10 released by activated keratinocytes, therefore, appears a
major stimulus for CD8+ (both Tc1 and Tc2) recruitment into
in¯amed skin. In contrast MDC and TARC secreted by immature
and mature DC can be strongly involved in the accumulation of
Th1 and Th2 CD4+ T lymphocytes. Although in vitro results may
not completely re¯ect the complexity of the in vivo situation, our
®ndings may also explain the relative distribution of CD4+ and
CD8+ lymphocytes in the in®ltrate of ACD, with a predominant
CD4+ T cell in®ltrate in the dermis, and an enrichment in CD8+ T
cells in the epidermis (Garmann and Gollnick, 1995). Our study
focused on the in vitro migratory properties of nickel-speci®c T
lymphocytes isolated from the peripheral blood of allergic individ-
uals, which are supposed to include the entire repertoire of T cells
that can be potentially recruited during the immune reaction to the
hapten. In this respect, they could be more representative than T
cells isolated directly from ACD skin, whose composition and
migratory capability are affected by the time of the biopsy and the
different state of activation of the diverse T cell subsets migrated
into the skin.
In conclusion, the recruitment of T cell subsets during
in¯ammatory skin diseases is promoted by the release of
chemokines preferentially released by distinct resident cell popu-
lations. The diverse chemokine responsiveness of CD8+ and CD4+
T cells suggests novel therapeutic interventions based on the
selective modulation of their recruitment into the skin.
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